Literature DB >> 8192861

Extensive nitration of protein tyrosines in human atherosclerosis detected by immunohistochemistry.

J S Beckmann1, Y Z Ye, P G Anderson, J Chen, M A Accavitti, M M Tarpey, C R White.   

Abstract

Oxidation of lipoproteins is important for the initiation and propagation of the atherosclerotic lesion and may involve secondary oxidants derived from nitric oxide. Nitric oxide (NO) reacts at near diffusion limited rates with superoxide (O2-.) to form the strong oxidant, peroxynitrite (ONOO-). Nitration on the ortho position of tyrosine is a major product of peroxynitrite attack on proteins. Nitrotyrosine was detected in atherosclerotic lesions of formalin-fixed human coronary arteries with polyclonal and monoclonal antibodies. Binding was pronounced in and around foamy macrophages within the atheroma deposits. Nitration was also observed in early subintimal fatty streaks. Antibody binding was completely blocked by co-incubation with 10mM nitrotyrosine, but not by equivalent concentrations of aminotyrosine or phosphotyrosine. The presence of nitrotyrosine indicates that oxidants derived from nitric oxide such as peroxynitrite are generated in human atherosclerosis and may be involved in its pathogenesis.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8192861     DOI: 10.1515/bchm3.1994.375.2.81

Source DB:  PubMed          Journal:  Biol Chem Hoppe Seyler        ISSN: 0177-3593


  187 in total

1.  Quantification of 3-nitrotyrosine in biological tissues and fluids: generating valid results by eliminating artifactual formation.

Authors:  D Yi; B A Ingelse; M W Duncan; G A Smythe
Journal:  J Am Soc Mass Spectrom       Date:  2000-06       Impact factor: 3.109

2.  Histone H1.2 is a substrate for denitrase, an activity that reduces nitrotyrosine immunoreactivity in proteins.

Authors:  Yasuyuki Irie; Makio Saeki; Yoshinori Kamisaki; Emil Martin; Ferid Murad
Journal:  Proc Natl Acad Sci U S A       Date:  2003-04-28       Impact factor: 11.205

3.  Nitric oxide induces heat-shock protein 70 expression in vascular smooth muscle cells via activation of heat shock factor 1.

Authors:  Q Xu; Y Hu; R Kleindienst; G Wick
Journal:  J Clin Invest       Date:  1997-09-01       Impact factor: 14.808

4.  Surfactant protein A mediates mycoplasmacidal activity of alveolar macrophages by production of peroxynitrite.

Authors:  J Hickman-Davis; J Gibbs-Erwin; J R Lindsey; S Matalon
Journal:  Proc Natl Acad Sci U S A       Date:  1999-04-27       Impact factor: 11.205

5.  Confident identification of 3-nitrotyrosine modifications in mass spectral data across multiple mass spectrometry platforms.

Authors:  Bensheng Li; Jason M Held; Birgit Schilling; Steven R Danielson; Bradford W Gibson
Journal:  J Proteomics       Date:  2011-04-15       Impact factor: 4.044

Review 6.  Oxidative stress in systemic lupus erythematosus and antiphospholipid syndrome: a gateway to atherosclerosis.

Authors:  José Delgado Alves; Bruno Grima
Journal:  Curr Rheumatol Rep       Date:  2003-10       Impact factor: 4.592

7.  Argpyrimidine, a methylglyoxal-derived advanced glycation end-product in familial amyloidotic polyneuropathy.

Authors:  Ricardo Gomes; Marta Sousa Silva; Alexandre Quintas; Carlos Cordeiro; António Freire; Paulino Pereira; Américo Martins; Estela Monteiro; Eduardo Barroso; Ana Ponces Freire
Journal:  Biochem J       Date:  2005-01-15       Impact factor: 3.857

8.  Identification of nitrotyrosine containing peptides using combined fractional diagonal chromatography (COFRADIC) and off-line nano-LC-MALDI.

Authors:  Trine R Larsen; Nicolai Bache; Jan Bert Gramsbergen; Peter Roepstorff
Journal:  J Am Soc Mass Spectrom       Date:  2011-03-08       Impact factor: 3.109

9.  Oxidative stress markers and micronutrients in maternal and cord blood in relation to neonatal outcome.

Authors:  D Weber; W Stuetz; W Bernhard; A Franz; M Raith; T Grune; N Breusing
Journal:  Eur J Clin Nutr       Date:  2013-12-11       Impact factor: 4.016

Review 10.  Endothelial nitric oxide synthase and endothelial dysfunction.

Authors:  Paul L Huang
Journal:  Curr Hypertens Rep       Date:  2003-12       Impact factor: 5.369

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.